文献速递神经MR

3T场强下MR酰胺质子转移(APT)与扩散峰度成像(DKI)在胶质瘤分级及IDH突变状态预测中的诊断效能比较

Diagnostic performance between MR amide proton transfer (APT) and diffusion kurtosis imaging (DKI) in glioma grading and IDH mutation status prediction at 3 T.
PubMed 文献 · Eur J Radiol · 2020-12-03

回顾性纳入51例未治疗胶质瘤患者,比较APT加权效应与DKI各指标在胶质瘤分级和IDH突变状态预测中的诊断效能。ΔAPTw在肿瘤分级和IDH突变状态间均有显著差异(P<0.05),鉴别效能持续优于DKI指标。结论认为APT成像在胶质瘤分级和IDH突变状态预测方面优于DKI。

要点

  • ΔAPTw在胶质瘤分级和IDH突变状态预测中鉴别效能持续优于DKI各指标。
  • MD与MK在胶质瘤IV级与II/III级间有显著差异,但II级与III级间无显著差异。
  • FA与KFA在三组胶质瘤间均无显著差异。

核心结论

  • APT成像在胶质瘤分级和IDH突变状态预测方面优于DKI,有助于准确诊断和治疗决策。

研究设计与样本

  • 回顾性纳入51例未治疗的胶质瘤患者。
  • 从APT和扩散加权图像分别获得APTw效应及DKI指标(MD、FA、MK、KFA),并将肿瘤区DKI指标对侧正常表现白质(CNAWM)进行标准化,计算两区域间APTw差值(ΔAPTw)。
  • 采用Student t检验、单因素方差分析和ROC分析进行统计。

关键影像表现/征象

  • 51例中胶质瘤II级13例、III级17例、IV级21例;IDH突变型25例,IDH野生型26例。
  • MD和MK在胶质瘤IV级与II/III级间差异显著(P<0.05),但在II级与III级间无显著差异。
  • FA和KFA在三组间均无显著差异(P>0.05)。
  • IDH突变型组MD显著高于IDH野生型组,FA、MK和ΔAPTw显著低于IDH野生型组(P<0.05),两组KFA值相当。
  • ΔAPTw在不同肿瘤级别和IDH突变状态间均有显著差异(P<0.05),鉴别效能持续优于DKI指标。

诊断标准与关键数值

  • ΔAPTw在胶质瘤分级和IDH突变状态预测中的鉴别效能优于DKI指标(原文未报告具体阈值、敏感度、特异度或AUC数值)。

临床应用与阅片要点

  • 作者认为APT成像在胶质瘤分级和IDH突变状态预测方面优于DKI,有助于准确诊断和治疗决策。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

PURPOSE: Accurate glioma grading and IDH mutation status prediction are critically essential for individualized preoperative treatment decisions. This study aims to compare the diagnostic performance of magnetic resonance (MR) amide proton transfer (APT) and diffusion kurtosis imaging (DKI) in glioma grading and IDH mutation status prediction.

METHOD: Fifty-one glioma patients without treatment were retrospectively included. APT-weighted (APTw) effect and DKI indices, including mean diffusivity (MD), fractional anisotropy (FA), mean kurtosis (MK), and kurtosis FA (KFA) were obtained from APT and diffusion-weighted images, respectively. DKI indices in tumors were normalized to that in contralateral normal appearing white matter (CNAWM) and the APTw difference (ΔAPTw) between the two regions was calculated. Student's t-test, one-way ANOVA and ROC analyses were conducted.

RESULTS: Among the enrolled 51 patients, 13 had glioma-II, 17 had glioma-III and 21 had glioma-IV. 25 patients were diagnosed as IDH-mutant, and 26 as IDH-wild type. MD and MK differed significantly between glioma-IV and glioma II/III (P < 0.05), but not between glioma-II and glioma-III. FA and KFA showed no significant difference among the three groups (P > 0.05). IDH-mutant group exhibited significantly higher MD and lower FA, MK and ΔAPTw than IDH-wild type (P < 0.05), whereas the two groups showed comparable KFA values. In contrast, ΔAPTw differed significantly across tumor grades and IDH mutation status (P < 0.05), with consistently better discriminatory performance than DKI indices in glioma grading and IDH mutation status prediction.

CONCLUSIONS: APT imaging was superior to DKI in glioma grading and IDH mutation status prediction, benefiting accurate diagnoses and treatment decisions.

来源:Eur J Radiol,查看原文。版权归原作者所有。

引用

  1. Xu Z, Ke C, Liu J, et al. Diagnostic performance between MR amide proton transfer (APT) and diffusion kurtosis imaging (DKI) in glioma grading and IDH mutation status prediction at 3 T. Eur J Radiol. 2020. PMID: 33307459. doi:10.1016/j.ejrad.2020.109466

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。